Will we ever use stem cells for the treatment of SUI?: ICI-RS 2011

Neurourology and Urodynamics

Volumn 31, Issue 3, 2012, Pages 386-389

  Goldman, Howard B ^a   Sievert, Karl Dietrich ^b   Damaser, Margot S ^a,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

mesenchymal stem cells; stem cells; stress; urethra; urinary incontinence

Indexed keywords

ADIPOSE DERIVED STEM CELL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CONVALESCENCE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE DERIVED STEM CELL; NONHUMAN; PATIENT SAFETY; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; STRESS INCONTINENCE; TREATMENT INDICATION; URETHRA FUNCTION;

ANIMALS; EVIDENCE-BASED MEDICINE; HUMANS; RECOVERY OF FUNCTION; REGENERATION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; URETHRA; URINARY INCONTINENCE, STRESS;

EID: 84859106164     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.22217     Document Type: Review

References (21)

1. Meirelles L, Fontes AM, Covas DT, et al. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009; 20: 419-27.
2. Stem Cell Treatment-Stem Cell Research-Stem Cell Therapy. accessed 12/21/2011.
3. Bonfield TL,. Adult mesenchymal stem cells: A innovative therapeutic for lung diseases. accessed 12/21/2011.
4. Wu X, Want S, Chen B, et al. Muscle-derived stem cells: Isolation, characterization, differentiation, and application in cell and gene therapy. Cell Tissue Res 2010; 340: 549-67.
5. Cruz M, Dissaranan C, Cotleur A, et al. Pelvic organ distribution of mesenchymal stem cells injected intravenously after simulated childbirth injury in female rats. Obstet Gynecol Int 2012 DOI: 10.1155/2012/612946
6. Chermansky CJ, Tarin T, Kwon D, et al. Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency. Urology 2004; 63: 780-5.
7. Kim S, Na HS, Kwon D, et al. Bone-marrow-derived mesenchymal stem cell transplantation enhances closing pressure and leak point pressure in a female urinary incontinence rat model. Urol Int 2011; 86: 110-16.
8. Lin G, Wang G, Banie L, et al. Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy 2010; 12: 88-95.
9. Strasser H, Marksteiner R, Margreiter E, et al. Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: A randomized controlled trial. Lancet 2007; 369: 2179-86.
10. Kleinert S, Horton R,. Retraction-Autologous myoblasts and fibroblasts for treatment of stress urinary incontinence: A randomized controlled trial. Lancet 2008; 372: 789-90.
11. Carr LK, Steele D, Steele S, et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J 2008; 19: 881-3.
12. Peters K, Kaufman M, Dmochowski R, et al. Autologous muscle derived cell therapy for the treatment of female stress urinary incontinence: A multi-center experience. J Urol 2011; 185: e535-e536.
13. Elmi A, Kajbafzadeh A, Tourchi A, et al. Safety, efficacy and health related quality of life of autologous myoblast transplantation for treatment of urinary incontinence in children with bladder exstrophy-epispadias complex. J Urol 2011; 186: 2021-6.
14. Xu Y, Song YF, Lin ZX,. Transplantation of muscle-derived stem cells plus biodegradable fibrin glue restores the urethral sphincter in a pudendal nerve-transected rat model. Braz J Med Biol Res 2010; 43: 1076-83.
15. Zhao W, Zhang C, Jin C, et al. Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model. Eur Urol 2011; 59: 155-63.
16. Zou XH, Zhi YL, Chen X, et al. Mesenchymal stem cell seeded knitted silk sling for the treatment of stress urinary incontinence. Biomaterials 2010; 31: 4872-9.
17. Dresske B, El Mokhtari NE, Ungefroren H, et al. Multipotent cells of monocytic origin improve damaged heart function. Am J Transplant 2006; 6: 947-58.
18. Singer NG, Caplan AI,. Mesenchymal stem cells: Mechanisms of inflammation. Annu Rev Pathol Mech Dis 2011; 6: 457-78.
19. Dissaranan C, Cruz M, Gill B, et al. Intravenous mesenchymal stem cells home to the urethra and facilitate recovery from stress urinary incontinence after childbirth injury via local secretion of paracrine factors. J Urol 2011; 185: e73.
20. Sundararaman S, Miller TJ, Pastore JM, et al. Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure. Gene Ther 2011; 18: 867-73.
21. Drost A, Weng S, Feil G, et al. In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair. Ann NY Acad Sci 2009; 1176: 135-43.